Description
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Purity | ≥98% |
|---|---|
| Formula | C18H18O4 |
| Formula Wt. | 298.33 |
| IUPAC Name | 2-phenylethyl 3-(3-hydroxy-4-methoxyphenyl)propanoate |
| Appearance | White Crystal Powder |
| Store Temp | 4°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Pereira MA. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs. Adv Exp Med Biol. 1999;470:55-63. PMID: 10709674.
Synthesis impurity
Synthetic hydrocortisone derivative; glucocorti...
Specific inhibitor of histone methyltransferase...
Nucleoside (cytidine) analog; RT and telomerase...
AurKA inhibitor.
Polyanionic sulfated glycosaminoglycan, endogen...
SERT, NET, MAO inhibitor.
Synthetic derivative of selenocyanate.
Mixture of Ginkgolides A, B and C, found in Gin...
Prolyl hydroxylase inhibitor.
Heterocyclic light-emitting compound, natural l...
p110α PI3K inhibitor.
Endogenous anionic non-sulfated glycosaminoglyc...
Tropane alkaloid found in Solanaceae plants; M1...
Potent and selective inhibitor
TLR4 inhibitor.
Peptide found in amphibian skin; GRP (BB1) and ...
Histamine H2 antagonist, GSK-3β inhibitor.
Cannabinoid receptor 2 selective agonist.
Antioxidant, vitamin E derivative found in vege...